David Gallagher

Popular Topics

Intellectual Property

DETAILS

United Kingdom

+44 20 3077 8600

AUTHORS CONTENT

Gene Therapy And US Patent Eligibility Update: REGENXBIO, Inc. v. Sarepta Therapeutics, Inc.

United States IP

Navigating The Inescapable Trap – Added Matter At The EPO (Video)

United States IP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More